Biofrontera Inc. Reports First Quarter 2024 Financial Result

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three mon...

Related Keywords

United States , Hermann Luebbert , Andrew Barwicki , Biofrontera Bioscience Gmb , Twitter , Nasdaq , Biofrontera Inc , Exchange Commission , Drug Administration , Change Healthcare , New Drug Application , Biofrontera Bioscience Gmbh , Chief Executive Officer , Preferred Stock , Months Ended March ,

© 2025 Vimarsana